41 native tech companies, institutes and college spin-offs head to San Diego to forge world partnerships, reinforcing the town’s standing as worldwide healthcare innovation hub
HONG KONG SAR/SAN DIEGO, UNITED STATES – Media OutReach Newswire – 24 June 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK as co-organiser, the Hong Kong Trade Development Council (HKTDC) as supporting organisation, and 5 famend native universities – The University of Hong Kong, The Chinese University of Hong Kong, The Hong Kong University of Science and Technology, The Hong Kong Polytechnic University and City University of Hong Kong – to kind the town’s largest-ever delegation of life and well being know-how innovators to the BIO International Convention 2026 (BIO 2026) in San Diego, from June 22 to 25.
In collaboration with InvestHK and HKTDC, HKSTP led a delegation of 41 park corporations, institutes and spin-offs from 5 famend native universities to showcase the Hong Kong’s life and well being know-how improvements at BIO 2026 in San Diego. 
Building on final 12 months’s momentum, the 2026 Hong Kong delegation doubled the scale of the Hong Kong Pavilion, increasing to a file of 41 organisations from HKSTP, together with accomplice corporations, analysis institutes, and for the primary time with prime 5 universities spin-offs. This landmark presence showcased Hong Kong’s deep energy throughout AI-enabled biotech, therapeutics, diagnostics, and pharma innovation, with potential excellent “First-in-Class” and “Best-in-Class” belongings. The delegation underscores the town’s main function as Asia’s largest and the world’s second largest fundraising hub for the biotechnology sector.
Mr. Terry Wong, CEO of HKSTP, stated, “BIO 2026 is a premier platform to showcase Hong Kong’s groundbreaking innovation, deepen partnerships, and open new pathways into global healthcare markets. As a super-connector, Hong Kong is uniquely positioned to bridge global innovators with opportunities across Asia and beyond. With strong R&D capabilities backed by world-class universities—five ranked among the QS Top 100, including two with medical schools now placed in the global top 20—Hong Kong’s biotech and medical research excellence is increasingly recognised worldwide. As the city’s innovation ecosystem orchestrator, HKSTP brings together talent, capital, research institutions, clinical partners, and industry leaders to accelerate the journey from discovery to impact. We will continue to empower life and health technology ventures, translating innovation breakthroughs into life-changing solutions that benefit communities around the world.”
HKSTP and Park Companies Advanced in Cross-border Innovation and Market Expansion
A key spotlight of BIO 2026 is witnessing the signing of three main strategic partnerships:
- LabCentral — HKSTP signed an MOU with one of many largest world non–revenue biotech incubators, supporting life sciences startups with high-impact lab infrastructure and scientific neighborhood programmes. The collaboration will deepen ties between the U.S. and Hong Kong life sciences ecosystems by means of startup help, ecosystem engagement, and co-developed programmes, occasions and strategic initiatives. It may even assist join startups, traders, company companions and analysis establishments, creating stronger pathways for cross-border innovation and commercialisation.
- Immuno Cure – the developer of the first-in-human novel therapeutic HIV vaccine ICVAX – introduced its collaboration with OPIS, a global Contract Research Organization (CRO), at BIO 2026. Leveraging OPIS’s full-service, multi-country scientific trial experience and regulatory data, the partnership will help abroad scientific trial execution and set up a world framework to put together for worldwide enlargement.
- Zhaoke Ophthalmology signed an MOU with Laboratório Teuto, the primary firm to produce generic medicines and OTCs (Over the Counter – Prescription Exempt Medicines) in Brazil, to discover cross-border cooperation in ophthalmology. This is Zhaoke’s first strategic MOU in Brazil market. Leveraging its revolutionary pipeline and Teuto’s business community in Brazil, the partnership goals to deliver superior eye care therapies to Latin American sufferers whereas demonstrating the globalisation of Hong Kong-born biotech innovation.
Beyond the BIO 2026 Hong Kong Pavilion, HKSTP CEO Mr Terry Wong attended the “Translating Innovation Across Borders: Creating Global Gateways for Biotech Startups” panel sharing session. Mr. Wong shared his insights on cutting-edge biotech tendencies, Hong Kong’s strengths on life and well being tech improvement, and HKSTP’s function in constructing a world bridge for nurturing world startup enlargement, sustainable innovation and collaboration.
Furthermore, HKSTP and 5 Hong Kong college delegates visited the Salk Institute, house to six Nobel Laureates throughout BIO 2026 to discover partnerships and form world biotech momentum by means of collaborative platforms. HKSTP, in collaboration with InvestHK as co-organiser, HKTDC because the supporting organisation, and powered by the Hong Kong Economic and Trade Office in San Francisco, hosted a Global Mixer throughout the exhibition. Industry leaders, incubators, and enterprise capital companies – together with Bayer Pharmaceuticals, Johnson & Johnson Innovation, LabCentral, Roche, Simcere Pharmaceutical, and T.Rx Capital – have been invited to be a part of the judging panel for startup pitching periods. The Pavilion additionally featured govt sharing and curated networking occasions for commercialisation, licensing, partnerships, funding and worldwide market enlargement.
Global recognition at Biomedical Pitch Competition
In the lead-up to BIO 2026, HKSTP actively drove engagement throughout the biotech sector and co-organised the 2026 Biomedical Pitch Competition with the Boston Capital Investment Club in Boston on May 23 and 24. Competing towards round 170 biotechnology corporations worldwide, HKSTP park firm Meta Pharmaceuticals (HK) Limited received Third Place for its next-generation autoimmune therapeutics. The recognition underscores the energy of Hong Kong’s biotech pipeline and HKSTP’s dedication to translational drugs, commercialisation and globally scalable healthcare options.
HK’s biotech ecosystem rises to one other stage
Hong Kong continues to develop its world healthcare footprint because the world’s second-largest biotech fundraising hub. As Hong Kong’s flagship innovation and know-how ecosystem, HKSTP is house to greater than 300 life and well being know-how corporations and helps innovators flip pioneering concepts into real-world impression. Its ecosystem connects capital, expertise, infrastructure and market entry throughout the biotech innovation journey.
Hashtag: #HKSTP
The issuer is solely accountable for the content material of this announcement.
Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, greater than 17,000 analysis professionals and over 2,500 know-how corporations from 26 international locations and areas targeted on growing healthtech, AI and robotics, fintech and good metropolis applied sciences, and so on.
Our rising innovation ecosystem gives complete help to appeal to and nurture expertise, speed up and commercialise innovation for know-how ventures, with the I&T journey constructed round our key places of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three trendy InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a imaginative and prescient of latest industrialisation for Hong Kong, the place sectors together with superior manufacturing, micro-electronics and biotechnology are being reimagined.
Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen performs constructive roles in connecting the world and the mainland with our proximity, strengthening cross-border change to deliver benefits in attracting world expertise and permitting prospects for the event of know-how corporations in seven key areas: Medtech, huge information and AI, robotics, new supplies, microelectronics, fintech and sustainability, with each dry and moist laboratories, co-working area, convention and exhibition services, and extra.
Through our R&D infrastructure, startup help and enterprise companies, commercialisation and funding experience, partnership networks and expertise traction, HKSTP continues to contribute in establishing I&T as a pillar of development for Hong Kong.
More details about HKSTP is out there at 
www.hkstp.org.
